PULSE@MassChallenge

Applications for the 2018 PULSE@MassChallenge program now open

Startups with less than $5M in both funding and revenue are invited to apply by the October 11 deadline, and get expert support and free office space.
Calorie Mama AI app - DNA enhanced

Azumio adds DNA-based insights into its Calorie Mama AI app

The app will lets users sequence their DNA so they could gain a deeper understanding of their body and its unique needs.
Verily Study Watch

Verily, Mindstrong join the fight against PTSD

The research study called Aurora is trying to figure out what biomarkers connect a traumatic event to the development and eventual diagnosis of PTSD.
Xiaomi Mi Band

Strategy Analytics: Xiaomi is the top wearables vendor in Q2 2017

The Chinese company managed to capture 17 percent of the market, overtaking Fitbit and Apple; global wearables shipments reached 21.6M units.

Fitbit’s smartwatch will be ready for the holidays

It will be water-proof up to 50m, have a multi-day battery life, and deliver the best health and fitness experience.
Fitbit Charge

Study: Fitbit doesn’t help teens exercise more

The eight-week-long study was looking to investigate whether fitness wearables could encourage young teenagers to take more exercise.
WYhealth Due Date Plus

Study proves that Wildflower Health’s maternity app can engage users

A Medicaid member was estimated to be 76% more likely to have a 6-month or more prenatal visit if she was the WYhealth Due Date Plus app user.
MedDialog steps

TELUS Health’s MedDialog enables seamless doctor-to-doctor communications across Canada

The technology promises to deliver more efficient clinical practice and better patient care while ensuring that all communication history remains within the digital chart.
Nucleus 7 Sound Processor

Cochlear Nucleus 7 Sound Processor is the category-first “Made for iPhone” product

The device lets people stream sound directly from their iPhones, as well as control, monitor and customize their hearing from the companion app.
eversense

Senseonics, TypeZero and Roche Diabetes Care team-up to trial a long-term artificial pancreas system

The trial will integrate Senseonics' Eversense CGM System with TypeZero's inControl AP algorithms and Roche's Accu-Chek Insight Insulin Pump.